917748-98-2 Usage
Uses
Used in Pharmaceutical Industry:
7-Amino-4-benzyl-4H-benzo[1,4]oxazin-3-one is used as a pharmaceutical candidate for its anti-tumor properties, where it may contribute to the development of new cancer therapies. Its anti-inflammatory activities also make it a potential candidate for the treatment of inflammatory diseases.
Used in Chemical Biology:
7-Amino-4-benzyl-4H-benzo[1,4]oxazin-3-one is used as a fluorescent probe for detecting metal ions, which can be instrumental in the study of metal ion interactions and their roles in biological systems.
Used in Research and Development:
In the field of research and development, 7-Amino-4-benzyl-4H-benzo[1,4]oxazin-3-one serves as a subject for further exploration of its biological and pharmacological properties, potentially leading to the discovery of new applications in medicine and other scientific disciplines.
Check Digit Verification of cas no
The CAS Registry Mumber 917748-98-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,7,4 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 917748-98:
(8*9)+(7*1)+(6*7)+(5*7)+(4*4)+(3*8)+(2*9)+(1*8)=222
222 % 10 = 2
So 917748-98-2 is a valid CAS Registry Number.
917748-98-2Relevant academic research and scientific papers
SMALL MOLECULE STING ANTAGONISTS
-
, (2021/08/20)
The present invention relates to compounds of formula (I). The compounds maybe used to antagonise the Stimulator of Interferon Genes (STING) protein and may thereby treat liver fibrosis, fatty liver disease, non-alcoholic steatohepatitis (NASH), pulmonary fibrosis, lupus, sepsis, rheumatoid arthritis (RA), type I diabetes, STING- associated vasculopathy with onset in infancy (SAVI), Aicardi-Goutieres syndrome (AGS), familial chilblain lupus (FCL), systemic lupus erythematosus (SLE), retinal vasculopathy, neuroinflammation, systemic inflammatory response syndrome, pancreatitis, cardiovascular disease, renal fibrosis, stroke and age-related macular degeneration (AMD).
BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS
-
Page/Page column 75, (2008/06/13)
The present invention relates to a compound, useful as a mineralocorticoid receptor-modulating agent, of the following formula [I]: wherein Ring A is a benzene ring optionally having a substituent(s) other than R1 etc, R1 is a group
